| TAUKLARIVY Cerveau Technologies, Inc.
98773945 27 Sep 2024 | on 27 Sep 2024 | pharmaceutical preparations, agents and substances for diagnostic imag... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations, agents and substances for diagnostic imaging; radiopharmaceutical imaging agents for detection, diagnosis and monitoring of Alzheimer's disease, neurological and neurodegenerative diseases and disorders, and brain conditions; diagnostic pharmaceutical preparations, agents and substances for detecting and monitoring of Tau neurofibrillary tangles to aid the evaluation/assessment of Alzheimer's disease and treatments, neurological and neurodegenerative diseases and disorders, and brain conditions | | | TAUKLERIZY Cerveau Technologies, Inc.
98773949 27 Sep 2024 | on 27 Sep 2024 | pharmaceutical preparations, agents and substances for diagnostic imag... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations, agents and substances for diagnostic imaging; radiopharmaceutical imaging agents for detection, diagnosis and monitoring of Alzheimer's disease, neurological and neurodegenerative diseases and disorders, and brain conditions; diagnostic pharmaceutical preparations, agents and substances for detecting and monitoring of Tau neurofibrillary tangles to aid the evaluation/assessment of Alzheimer's disease and treatments, neurological and neurodegenerative diseases and disorders, and brain conditions | | | TAUKLARIFY Cerveau Technologies, Inc.
98773935 27 Sep 2024 | on 27 Sep 2024 | pharmaceutical preparations, agents and substances for diagnostic imag... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations, agents and substances for diagnostic imaging; radiopharmaceutical imaging agents for detection, diagnosis and monitoring of Alzheimer's disease, neurological and neurodegenerative diseases and disorders, and brain conditions; diagnostic pharmaceutical preparations, agents and substances for detecting and monitoring of Tau neurofibrillary tangles to aid the evaluation/assessment of Alzheimer's disease and treatments, neurological and neurodegenerative diseases and disorders, and brain conditions | | 
